Physician Assistant · Portage, MI
NPI
1124112982
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6100 Newport Rd, Suite 100
Portage, MI, 49002
Phone (269) 343-4679
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
2,316 services
Medicare patients, 2024
597
Average age 75
Drug cost, 2024
$509K
1,771 prescriptions
Company payments, 2025
$928
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Therese A Birkam-Jade was code 17003 (destruction skin lesion), 651 times for 150 patients. In total Therese A Birkam-Jade billed 2,316 services in 49 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 651 | 150 | $3.35 | $2,181 |
| 99213 Office E&M - Established | Office | 509 | 410 | $44.69 | $23K |
| 17110 Destruction Skin Lesion | Office | 269 | 178 | $56.14 | $15K |
| 17000 Destruction Skin Lesion | Office | 252 | 196 | $32.08 | $8,084 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 167 | 32 | $0.55 | $92.13 |
| 96900 Skin | Office | 96 | 11 | $12.64 | $1,213 |
| 11102 Skin Biopsy | Office | 48 | 45 | $40.02 | $1,921 |
| 11900 Skin | Office | 46 | 17 | $18.29 | $841 |
| 99212 Office E&M - Established | Office | 39 | 37 | $27.98 | $1,091 |
| 96372 Injection Administration | Office | 36 | 22 | $6.60 | $238 |
| 99203 Office E&M - New | Office | 28 | 28 | $48.61 | $1,361 |
| 12032 Wound Repair - All Levels | Office | 28 | 26 | $159.81 | $4,475 |
| 11602 Skin Lesion Excision | Office | 20 | 19 | $77.92 | $1,558 |
By year: 2022 $85K for 3,005 services; 2023 $81K for 2,857 services; 2024 $71K for 2,316 services.
Medicare prescription drug claims, 2024
In 2024, the drug Therese A Birkam-Jade prescribed most often to Medicare patients was Triamcinolone Acetonide, with 222 prescriptions and refills. In total Therese A Birkam-Jade wrote 1,771 Medicare prescriptions that cost $509K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 222 | 273 | 130 | $2,243 |
| Betamethasone Valerate Generic | 156 | 183 | 91 | $6,337 |
| Clobetasol Propionate Generic | 142 | 201 | 64 | $6,178 |
| Ketoconazole Generic | 134 | 175 | 75 | $2,853 |
| Betamethasone Dipropionate Generic | 121 | 160 | 69 | $7,048 |
| Minocycline Hcl Generic | 80 | 118 | 24 | $2,392 |
| Metronidazole Generic | 71 | 86 | 51 | $3,158 |
| Clindamycin Phosphate Generic | 70 | 83 | 38 | $1,915 |
| Doxycycline Hyclate Generic | 51 | 87 | 22 | $1,024 |
| Desonide Generic | 36 | 55 | 23 | $2,006 |
| Azelaic Acid Generic | 36 | 41 | 23 | $4,784 |
| Mupirocin Generic | 35 | 35 | 22 | $316 |
| Methotrexate Methotrexate Sodium | 35 | 65 | Under 11 | $1,010 |
| Hydroxyzine Hcl Generic | 28 | 40 | Under 11 | $290 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 27 | 31 | Under 11 | $68.4 |
Brand drugs: 250 claims; generic drugs: 1,521 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Therese A Birkam-Jade $928 ($928 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $156.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 9 | $156 |
| Lilly USA, LLC LLY | 5 | $107 |
| Organon LLC OGN | 12 | $103 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $99.22 |
| LEO Pharma Inc. | 5 | $97.6 |
| Janssen Biotech, Inc. JNJ | 3 | $85.6 |
| Genzyme Corporation SNY | 3 | $80.7 |
| UCB, Inc. UCB.BR | 2 | $50.52 |
| Amgen Inc. AMGN | 2 | $36.17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.